-+ 0.00%
-+ 0.00%
-+ 0.00%

Prelude Therapeutics shareholders elect three directors at annual meeting

PUBT·06/10/2026 20:11:53
Listen to the news
Prelude Therapeutics shareholders elect three directors at annual meeting
  • Prelude Therapeutics held its annual stockholder meeting on June 9, 2026.
  • Stockholders backed the selection of Krishna Vaddi, Paul Scherer, Katina Dorton as directors for new three-year terms.
  • Ernst & Young was ratified as independent registered public accounting firm for fiscal 2026.
  • Stockholders endorsed holding the advisory executive-pay vote every year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prelude Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-265835), on June 10, 2026, and is solely responsible for the information contained therein.